GLUE Operating Cash Flow (Statement)
Monte Rosa Therapeutics Inc · Operating Cash Flow (Statement)
GLUE Operating Cash Flow (Statement)
Latest reported-$24.07Mperiod ending
GLUE Cash from Operations (-$6.17M → -$24.07M)
Annual operating cash flow (statement)
High-resolution chart · PNG
GLUE operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -22,798,000 | |
| 41,996,000 | |
| -43,802,000 | |
| -92,466,000 | |
| -59,363,000 | |
| -23,053,000 | |
| -6,173,000 |